[Federal Register Volume 62, Number 62 (Tuesday, April 1, 1997)]
[Rules and Regulations]
[Page 15391]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-8116]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
21 CFR Parts 556 and 558
Animal Drugs, Feeds, and Related Products; Tilmicosin Phosphate
Type A Medicated Article; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a final
rule that appeared in the Federal Register of December 27, 1996 (61 FR
68147). The document amended the animal drug regulations to reflect
approval of Elanco Animal Health's new animal drug application (NADA)
141-064 for use of a Type A medicated article containing tilmicosin
phosphate in manufacturing a Type B or Type C medicated feed indicated
for the control of swine respiratory disease associated with certain
bacterial organisms. The document was published with some errors. This
document corrects those errors.
EFFECTIVE DATE: December 27, 1996.
FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for
Veterinary Medicine (HFV-133), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 301-594-1644.
In FR Doc. 96-32881, appearing on p. 68147, in the Federal Register
of Friday, December 27, 1996, the following corrections are made:
Sec. 556.735 [Corrected]
1. On page 68148, in the second column, in line 2, ``7.2'' is
corrected to read ``7.5''.
Sec. 558.618 [Corrected]
2. On page 68148, in the second column, in paragraph (d)(1),
``181.8'' and ``363.6'' are corrected to read ``181'' and ``363'',
respectively.
Dated: February 7, 1997.
Robert C. Livingston,
Director, Office of New Animal Drug Evaluation, Center for Veterinary
Medicine.
[FR Doc. 97-8116 Filed 3-31-97; 8:45 am]
BILLING CODE 4160-01-F
